✦ LIBER ✦

A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer

✍ Scribed by Blakely, L. Johnetta; Schwartzberg, Lee; Keaton, Mark; Schnell, Fred; Henry, David; Epperson, Amanda; Walker, Mark S.

Book ID: 119320091
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 175 KB
Volume: 66
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2008.12.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

A phase I/II trial of weekly docetaxel a

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer

✍ Stinchcombe, Thomas E.; Bůžková, Petra; Choksi, Janak; Taylor, Mark; Bakri, Kama 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

6568 POSTER Phase II trial of the novel

6568 POSTER Phase II trial of the novel epothilone ZK-EPO as second-line therapy in patients with stage IIIB or stage IV non-small-cell lung cancer

✍ Gatzemeier, U.; vonPawel, J.; Eschbach, C.; Brune, A.; Wagner, A.; Giurescu, M.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Weekly combination chemotherapy with doc

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Donna Carrell; Ronald L. Drengler; Carroll Scroggin Jr.; F. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract ## BACKGROUND The goal of the current study was to evaluate the feasibility, toxicity, and efficacy of a novel combination of weekly docetaxel and gemcitabine for elderly patients and patients with poor performance status who had advanced‐stage small cell lung carcinoma (SCLC). ## MET

Gemcitabine (GEM) and Vindesine (VDS) in

Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients

✍ Santo, Antonio; Genestreti, Giovenzio; Terzi, Alberto; Azzoni, Paolo; Sava, Teod 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB